Home › Neuroendocrine Tumors

Neuroendocrine Tumors clinical trials recruiting in the U.S.

39 studies for Neuroendocrine Tumors are recruiting participants at sites across the United States.

Cities with the most studies

• Washington, DC11 studies
• St. Louis, MO9 studies
• Philadelphia, PA8 studies
• Houston, TX7 studies
• Columbus, OH7 studies
• Rochester, MN7 studies
• Portland, OR6 studies
• Cleveland, OH6 studies
• Mountain View, CA6 studies
• Boston, MA6 studies
• Dallas, TX6 studies
• Los Angeles, CA6 studies
• Chicago, IL6 studies
• San Francisco, CA5 studies
• Salt Lake City, UT5 studies
• Nashville, TN5 studies
• Seattle, WA5 studies
• Omaha, NE5 studies
• Jacksonville, FL5 studies
• Cedar Rapids, IA5 studies
• Ann Arbor, MI4 studies
• Detroit, MI4 studies
• Lexington, KY4 studies
• Durham, NC4 studies
• Grand Rapids, MI4 studies
• Milwaukee, WI4 studies
• Charlottesville, VA4 studies
• Fargo, ND4 studies
• New York City, NY4 studies
• Miami, FL4 studies
• Cincinnati, OH3 studies
• Arlington, VA3 studies
• Phoenix, AZ3 studies
• Birmingham, AL3 studies
• Orlando, FL3 studies
• Albuquerque, NM3 studies
• Tampa, FL3 studies
• Buffalo, NY3 studies
• New Orleans, LA3 studies
• Baldwin Park, CA3 studies

By state

• Alabama3 studies
• Arizona5 studies
• California13 studies
• Colorado3 studies
• Connecticut3 studies
• Florida9 studies
• Georgia3 studies
• Illinois7 studies
• Iowa6 studies
• Kentucky4 studies
• Louisiana4 studies
• Maryland13 studies
• Massachusetts8 studies
• Michigan8 studies
• Minnesota9 studies
• Missouri10 studies
• Nebraska5 studies
• New Mexico3 studies
• New York5 studies
• North Carolina5 studies
• North Dakota4 studies
• Ohio12 studies
• Oregon6 studies
• Pennsylvania8 studies
• Tennessee6 studies
• Texas10 studies
• Utah5 studies
• Virginia5 studies
• Washington5 studies
• Wisconsin6 studies

Recently updated studies

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.